Unaudited Financial Results For Quarter Ended June 2026
Filed with BSE · · 9 pages · English
Summary by 6ix AI
The financial results include total income and profit figures, which have been reviewed by the Audit Committee and the statutory auditors. The meeting commenced at three in the afternoon and concluded shortly thereafter, with the results being made available on the company's and BSE's websites. The filing includes a limited review report from the auditors confirming compliance with relevant regulations.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Titan Biotech
- Titan Biotech Limited Press Release Aug 05 2026
- Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30, 2026.
- Titan Biotech Limited Press Release Jun 25 2026
- Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
- Titan Biotech Limited Press Release Jun 23 2026
Later from Titan Biotech
- Board Meeting Outcome for Outcome Of Board Meeting Held On August 13, 2026
- Titan Biotech Limited Press Release Aug 13 2026
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Titan Biotech Limited Press Release Aug 14 2026
- Closure of Trading Window
Follow Titan Biotech into a list and get an email when it puts out news.
Follow Titan Biotech